Respiratory Syncytial Virus Infection
4 drugs2,273 FAERS reportsMedDRA PT
GET
/api/v1/reaction/respiratory-syncytial-virus-infectionReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Respiratory Syncytial Virus Infection (4)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Palivizumab2,08614%
- 2Nirsevimab18112%
- 3Clesrovimab19.1%
- 4Elapegademase51.7%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Bronchiolitis2 shared · 0.50
- Respiratory Syncytial Virus Bronchiolitis2 shared · 0.50
- Respiratory Syncytial Virus Test Positive2 shared · 0.50
- Product Administered To Patient Of Inappropriate Age2 shared · 0.33
- Viral Infection2 shared · 0.22
- Extra Dose Administered2 shared · 0.15
- Rhinorrhoea3 shared · 0.13
- Influenza3 shared · 0.05
- Wheezing2 shared · 0.04
- Nasopharyngitis2 shared · 0.02
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.